corporate_fare

Evommune Inc.

Address
1891 Page Mill Road

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
35
research centres
public
6
countries
person_search
35
investigators

Specializations

Dermatology

Research activity is centered on chronic spontaneous urticaria, with attention to persistent inflammatory skin disease and symptom control in adults affected by moderate to severe urticaria.

  • Chronic Spontaneous Urticaria
  • Inflammatory Skin Disorders
  • Pruritus

The sponsor’s current clinical focus is concentrated on therapeutic options for ongoing hives and related skin inflammation.

Allergy and Immunology

Clinical interest includes immune-mediated mechanisms underlying urticarial disease, with emphasis on conditions driven by recurrent wheals, itching, and fluctuating disease activity.

  • Immune-Mediated Urticaria
  • Allergic Skin Symptoms
  • Mast Cell–Related Inflammation

This area reflects a therapeutic emphasis on disorders at the intersection of allergy and immune dysregulation.

Inflammation and Symptom Control

The funded research addresses disease burden linked to recurrent inflammation, with outcomes relevant to itch, wheal formation, and overall symptom relief in chronic skin disease.

  • Inflammatory Pathways
  • Itch Management
  • Wheal Suppression

Therapeutic interest is directed toward improving control of persistent cutaneous symptoms in adults.

Clinical Therapeutics

Research is focused on evaluating a targeted treatment candidate for adult patients with chronic spontaneous urticaria, reflecting interest in new options for difficult-to-manage dermatologic disease.

  • Targeted Treatment Development
  • Adult Urticaria Care
  • Symptom Burden Reduction

The sponsor’s current pipeline activity is concentrated in specialized skin and immune therapeutics.

Sponsored Trials

Trial Name Country Status
Efficacy and Safety Evaluation of EVO756 Potassium in Adults with Moderate to Severe Chronic Spontaneous Urticaria: A Randomized, Double-Blind, Placebo-Controlled StudyBulgaria BulgariaGermany GermanyHungary HungaryItaly ItalyPoland PolandSpain SpainNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)

This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 35 sites collaborated multiple times

This sponsor has worked with 35 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Skin and Connective Tissue Diseases1 trial
    247 other sponsors

Partnered Research Centres

35 centres
location_city
assignment8
Ambulatoria Za Individualna Praktika Za Specializirana Izvunbolnichna Medicinska Pomost Po Alergologia Doktor Talyat Sali Cholak EOOD
Address
Ulitsa Vasil Levski 1 Office 49, 7200 Razgrad
Learn morearrow_forward
location_city
assignment714
Azienda Unita Sanitaria Locale Di Bologna
Address
Via Pietro Albertoni 15, 40138 Bologna
Learn morearrow_forward
location_city
assignment1047
Charite Universitaetsmedizin Berlin KöR
Address
Hindenburgdamm 30, Lichterfelde, 12203 Berlin
Learn morearrow_forward
location_city
assignment71
Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak sp.p.
Address
Ul. Ul. Sliczna 13, 50-566 Wroclaw
Learn morearrow_forward
location_city
assignment5
Clínica de asma y alergia Dres. Ojeda
Address
C/ Oquendo, 23, 28006 Madrid
Learn morearrow_forward
location_city
assignment204
Diagnostic-consultative center “Aleksandrovska” EOOD
Address
Triaditsa, Ulitsa Sveti Georgi Sofiyski 1, 1431 Sofia
Learn morearrow_forward
Page 1 of 6

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Evommune Inc..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.